Form 4 Parabilis Medicines For: 22 July
- Investing.com
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Parabilis Medicines Inc (PBLS)
Parabilis Medicines Inc stock price live, this page displays NASDAQ PBLS stock exchange data. View the PBLS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Parabilis Medicines Inc real time stock price chart below.
What Is the Parabilis Medicines Inc Stock Price Today?
The Parabilis Medicines Inc stock price today is 39.37.
What Is the Stock Symbol for Parabilis Medicines Inc?
The stock ticker symbol for Parabilis Medicines Inc is PBLS.
Is PBLS the Same as $PBLS?
$PBLS is a common way to refer to the Parabilis Medicines Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Parabilis Medicines Inc Trade On?
Parabilis Medicines Inc is listed and trades on the NASDAQ stock exchange.
Is Parabilis Medicines Inc a Good Stock to Buy?
Determining whether Parabilis Medicines Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Parabilis Medicines Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PBLS quote. (ISIN: US6989551014)
What Is the Parabilis Medicines Inc Stock Price Today?
The Parabilis Medicines Inc stock price today is 39.37.
What Is the Stock Symbol for Parabilis Medicines Inc?
The stock ticker symbol for Parabilis Medicines Inc is PBLS.
Is PBLS the Same as $PBLS?
$PBLS is a common way to refer to the Parabilis Medicines Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Parabilis Medicines Inc Trade On?
Parabilis Medicines Inc is listed and trades on the NASDAQ stock exchange.
Is Parabilis Medicines Inc a Good Stock to Buy?
Determining whether Parabilis Medicines Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Parabilis Medicines Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PBLS quote. (ISIN: US6989551014)
NASDAQ
Currency in USD
39.38
-0.21(-0.52%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
38.95
40.92
52 wk Range
24.51
41.49
PBLS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
38.9540.92
52 wk Range
24.5141.49
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PBLS Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
41.75
Upside
+6.02%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 41.75
(+6.02% Upside)
Earnings
Latest Release
Aug 13, 2026
EPS / Forecast
-2.32 / --
Revenue / Forecast
100K / --
Compare PBLS to Peers and Sector
Metrics to compare | PBLS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPBLSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −21.0x | −3.3x | −0.3x | |
PEG Ratio | - | −0.05 | 0.00 | |
Price / Book | 4.6x | 2.2x | 2.6x | |
Price / LTM Sales | 32,911.6x | 8.2x | 3.1x | |
Upside (Analyst Target) | 3.6% | 271.5% | 47.6% | |
Fair Value Upside | Unlock | 12.3% | 5.6% | Unlock |
Parabilis Medicines, Inc. operates as a clinical-stage biopharmaceutical company focused on developing helical peptide therapeutics for disease treatment. The company develops stabilized helical peptide therapeutics through its Helicon discovery platform, targeting proteins that are traditionally considered undruggable. Its pipeline includes functional inhibitors of intracellular protein-protein interactions, targeted protein degraders, and targeted radiopharmaceuticals, with a lead clinical program, FOG-001, that acts as a TCF-blocking beta-catenin inhibitor for cancer treatment. The company integrates artificial intelligence and data science into drug discovery, trial design, and clinical strategy optimization. Parabilis Medicines serves clients in the healthcare and life sciences industries, including clinical research organizations and medical professionals involved in oncology and cancer treatment. The company was founded in 2015 and is based in Cambridge, Massachusetts.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Parabilis Medicines (PBLS) Stock Price Today?
The Parabilis Medicines stock price today is 39.38 USD.
What Stock Exchange Does Parabilis Medicines Trade On?
Parabilis Medicines is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Parabilis Medicines?
The stock symbol for Parabilis Medicines is "PBLS."
What Is the Parabilis Medicines Market Cap?
As of today, Parabilis Medicines market cap is 4.89B USD.
What Is Parabilis Medicines's Earnings Per Share (TTM)?
The Parabilis Medicines EPS (TTM) is -23.45.
From a Technical Analysis Perspective, Is PBLS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Parabilis Medicines Stock Split?
Parabilis Medicines has split 0 times.
How Many Employees Does Parabilis Medicines Have?
Parabilis Medicines has 145 employees.
What is the current trading status of Parabilis Medicines (PBLS)?
As of Aug 21, 2026, Parabilis Medicines (PBLS) is trading at a price of 39.38 USD, with a previous close of 39.58 USD. The stock has fluctuated within a day range of 38.95 USD to 40.92 USD, while its 52-week range spans from 24.51 USD to 41.49 USD.
What Is Parabilis Medicines (PBLS) Price Target According to Analysts?
The average 12-month price target for Parabilis Medicines is 41.75 USD, with a high estimate of 45 USD and a low estimate of 40 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +6.02% Upside potential.
What Is the PBLS Premarket Price?
PBLS's last pre-market stock price is 40.00 USD. The pre-market share volume is 950.00, and the stock has decreased by 0.42, or 1.06%.
What Is the PBLS After Hours Price?
PBLS's last after hours stock price is 39.70 USD, the stock has decreased by 0.12, or 0.30%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.